Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

GH stock hub

Guardant Health, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

GHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.7B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

In the news

Latest news · GH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-21.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All GH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001576280
Company name	Guardant Health, Inc.
Country	United States
Country code	US
Cusip	40131M109
Employees	2,506
Employees Change	485%
Employees Change Percent	24
Enterprise value	$13.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	2018-10-04
Isin	US40131M1099
Last refreshed	2026-05-10
Market cap	$12.7B
Market cap category	Large-Cap
Price	$95.7
Price currency	USD
Rev Per Employee	431,051.48x
Sector	Healthcare
Sic	8071
Symbol	GH
Website	https://guardanthealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.41%
EV Sales Forward	9.55x
EV/Sales	12.3x
FCF yield	-1.87%
P/S ratio	11.75x
PS Forward	9.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-41.39%
EBITDA Margin	-37.78%
Gross margin	64.9%
Gross Profit	$701M
Gross Profit Growth	47.65%
Gross Profit Growth Q	52.81%
Gross Profit Growth3 Y	32.01%
Gross Profit Growth5 Y	28.89%
Net Income	$-433.2M
Net Income Growth Years	3%
Pretax Margin	-40.21%
Profit Margin	-40.1%
Profit Per Employee	$-172,862
ROA	-17.15
Roa5y	-15.9
ROCE	-27.55
ROIC	-21.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	140.96%
Cagr3y	59.34%
Cagr5y	-6.7%
EPS Growth Years	3
Revenue Growth	39.56x
Revenue Growth Q	48.26x
Revenue Growth Quarters	31x
Revenue Growth Years	9x
Revenue Growth3 Y	30.85x
Revenue Growth5 Y	29.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.66
Assets	$1.9B
Cash	$1.1B
Current Assets	$1.4B
Current Liabilities	$292.1M
Debt	$1.7B
Equity	$-181.1M
Interest Coverage	-83.85
Liabilities	$2.1B
Long Term Assets	$547.8M
Long Term Liabilities	$1.8B
Net Cash	$-601.8M
Net Cash By Market Cap	$-4.74
Tangible Book Value	$-283.9M
Tangible Book Value Per Share	$-2.16
WACC	10.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.68
Inventory Turnover	4.71
Net Working Capital	$630,000
Quick ratio	4.25
Working Capital	$1.1B
Working Capital Turnover	$1.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.2%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	140.82%
200-day SMA	84.72
3Y total return	304.65%
50-day SMA	88.68
50-day SMA vs 200-day SMA	50over200
5Y total return	-29.32%
All Time High	181.1
All Time High Change	-47.15%
All Time High Date	2021-02-12
All Time Low	15.81
All Time Low Change	505.31%
All Time Low Date	2024-04-19
ATR	5.47
Beta	1.49
Beta1y	1.19
Beta2y	1.34
Ch YTD	-6.31
High	98.5
High52	120.7
High52 Date	2026-01-22
High52ch	-20.74%
Low	89.07
Low52	36.36
Low52 Date	2025-05-23
Low52ch	163.2%
Ma50ch	7.92%
Premarket Change Percent	4.78
Premarket Price	$96.67
Premarket Volume	4,036
Price vs 200-day SMA	12.96%
RSI	60.66
RSI Monthly	61.61
RSI Weekly	55.35
Sharpe ratio	1.77x
Sortino ratio	3.27
Total Return	-3.2%
Tr YTD	-6.31
Tr1m	2.57%
Tr1w	9.25%
Tr3m	-6.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	19
Analyst Count Top	2
Analyst Price Target Top	$130
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.52
Earnings Revenue Estimate	278,949,136x
Earnings Revenue Estimate Growth	37.1x
Operating Income	$-447.1M
Operating margin	-41.39
Price target	$121
Price Target Change	$26
Price Target Change Top	$35.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	127,179,439%
Float Percent	95.91%
Net Borrowing	402,500,000
Shares Insiders	4.09%
Shares Institutions	98.91%
Shares Out	132,599,929
Shares Qo Q	2.03%
Shares Yo Y	3.2%
Short Float	9.15%
Short Ratio	5.67
Short Shares	8.78

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-413.2M
Average Volume	2,038,344.35x
Bv Per Share	-1.38
CAPEX	$-49.4M
Ch1m	2.57
Ch1w	9.25
Ch1y	140.8
Ch3m	-6.04
Ch3y	304.7
Ch5y	-29.32
Ch6m	-1.05
Change	3.73%
Change From Open	-0.9
Close	92.26
Days Gap	4.67
Depreciation Amortization	38,942,000
Dollar Volume	304,974,846
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-447.1M
EBITDA	$-408.2M
EPS	$-3.4
F Score	4
FCF	$-237.1M
FCF EV Yield	-1.78x
FCF Per Share	$-1.79
Financing CF	716,406,000
Fiscal Year End	December
Founded	2,011
Goodwill	77,257,000
Income Tax	$-1.2M
Investing CF	-230,648,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-19
Ma150	94.13
Ma150ch	1.66%
Ma20	88.39
Ma20ch	8.27%
Net CF	297,588,000
Next Earnings Date	2026-07-29
Open	96.57
Optionable	Yes
Position In Range	70.31
Post Close	95.7
Postmarket Change Percent	-0.73
Postmarket Price	$95
Ppne	303,941,000
Pre Close	92.26
Price Date	2026-05-08
Relative Volume	1.56x
Revenue	1,080,215,000x
SBC By Revenue	16.3x
Share Based Comp	176,068,000
Tax By Revenue	-0.11x
Tr6m	-1.05%
Us State	California
Volume	3,186,780
Z Score	0.82

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does GH pay a dividend?

Capital-return profile for this ticker.

Performance

GH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns GH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+98.9%

Float: +95.9% of shares outstanding

Insider ownership

+4.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

GH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.7

Neutral momentum band

Price vs 200-day MA

+13.0%

50/200-day relationship not available

Beta (5Y)

1.49

More volatile than the market

Sharpe ratio

1.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About GH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current GH stock rating?

Guardant Health, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full GH analysis?

The full report lives at /stocks/GH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for GH?

The latest report frames GH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the GH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.